{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:29:54Z","timestamp":1781850594029,"version":"3.54.5"},"reference-count":32,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,9,29]]},"DOI":"10.1536\/ihj.20-155","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T22:05:01Z","timestamp":1598997901000},"page":"1079-1083","source":"Crossref","is-referenced-by-count":18,"title":["Sudden Unexpected Death of Infantile Dilated Cardiomyopathy with &lt;i&gt;JPH2&lt;\/i&gt; and &lt;i&gt;PKD1&lt;\/i&gt; Gene Variants"],"prefix":"10.1536","volume":"61","author":[{"given":"Aya","family":"Miura","sequence":"first","affiliation":[{"name":"Department of Legal Medicine, Hyogo College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehito","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Japanese Red Cross Kyoto Daiichi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, Hyogo College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Japanese Red Cross Kyoto Daiichi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Nishio","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, Hyogo College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Soares P, Rocha G, Pissarra H, <i>et al<\/i>. Neonatal dilated cardiomyopathy. Rev Port Cardiol 2017; 36: 201-14.","DOI":"10.1016\/j.repc.2016.10.007"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Takeshima H, Komazaki S, Nishi M, Iino M, Kangawa K. Junctophilins: A novel family of junctional membrane complex proteins. Molecular Cell 2000; 6: 11-22.","DOI":"10.1016\/S1097-2765(00)00003-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Beavers DL, Landstrom AP, Chiang DY, Wehrens XH. Emerging roles of junctophilin-2 in the heart and implications for cardiac diseases. Cardiovasc Res 2014; 103: 198-205.","DOI":"10.1093\/cvr\/cvu151"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sabater-Molina M, Navarro M, Garcia-Molina Saez E, <i>et al<\/i>. Mutation in JPH2 cause dilated cardiomyopathy. Clin Genet 2016; 90: 468-9.","DOI":"10.1111\/cge.12825"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vanninen SUM, Leivo K, Seppala EH, <i>et al<\/i>. Heterozygous junctophilin-2 (JPH2) p. (Thr161Lys) is a monogenic cause for HCM with heart failure. PLoS One 2018; 13: e.0203422.","DOI":"10.1371\/journal.pone.0203422"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vasilescu C, Ojala TH, Brilhante V, <i>et al<\/i>. Genetic Basis of Severe Childhood-Onset Cardiomyopathies. JACC 2018; 72: 2324-38.","DOI":"10.1016\/j.jacc.2018.08.2171"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jones EG, Mazaheri N, Maroofian R, <i>et al<\/i>. Analysis of enriched rare variants in JPH2-encoded junctophilin-2 among Greater Middle Eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy. Sci Rep 2019; 9: 9038.","DOI":"10.1038\/s41598-019-44987-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet 2019; 393: 919-35.","DOI":"10.1016\/S0140-6736(18)32782-X"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kuo IY, Kwaczala AT, Nguyen L, Russell KS, Campbell SG, Ehrlich BE. Decreased polycystin 2 expression alters calcium-contraction coupling and changes beta-adrenergic signaling pathways. Proc Natl Acad Sci U S A 2014; 111: 16604-9.","DOI":"10.1073\/pnas.1415933111"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Malekshahabi T, Khoshdel Rad N, Serra AL, Moghadasali R. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions. J Cell Physiol 2019; 234: 12451-70.","DOI":"10.1002\/jcp.28094"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chebib FT, Hogan MC, El-Zoghby ZM, <i>et al<\/i>. Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies. Kidney Int Rep 2017; 2: 913-23.","DOI":"10.1016\/j.ekir.2017.05.014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suwa Y, Higo S, Nakamoto K, <i>et al<\/i>. Old-Age Onset Progressive Cardiac Contractile Dysfunction in a Patient with Polycystic Kidney Disease Harboring a PKD1 Frameshift Mutation. Int Heart J 2019; 60: 220-5.","DOI":"10.1536\/ihj.18-184"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Morita H. Secondary Cardiomyopathy in Polycystic Kidney Disease Syndrome. Int Heart J 2019; 60: 10-1.","DOI":"10.1536\/ihj.18-514"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Haas J, Frese KS, Peil B, <i>et al<\/i>. Atlas of the clinical genetics of human dilated cardiomyopathy. European Heart Journal 2015; 36: 1123-35.","DOI":"10.1093\/eurheartj\/ehu301"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Oshima Y, Yamamoto T, Ishikawa T, <i>et al<\/i>. Postmortem genetic analysis of sudden unexpected death in infancy: neonatal genetic screening may enable the prevention of sudden infant death. J Hum Genet 2017; 62: 989-95.","DOI":"10.1038\/jhg.2017.79"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gigli M, Begay RL, Morea G, <i>et al<\/i>. A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies. Front Cardiovasc Med 2016; 3: 21.","DOI":"10.3389\/fcvm.2016.00021"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Herman DS, Lam L, Taylor MR, <i>et al<\/i>. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012; 366: 619-28.","DOI":"10.1056\/NEJMoa1110186"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Boyden LM, Kam CY, Hern\u00e1ndez-Mart\u00edn A, <i>et al<\/i>. Dominant de novo DSP mutations cause erythrokeratodermia-cardiomyopathy syndrome. Hum Mol Genet 2016; 25: 348-57.","DOI":"10.1093\/hmg\/ddv481"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Schulz AL, Albrecht B, van der Burgt I, <i>et al<\/i>. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome. Clin Genet 2008; 73: 62-70.","DOI":"10.1111\/j.1399-0004.2007.00931.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Jin M, Xie Y, Chen Z, <i>et al<\/i>. System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease. Sci Rep 2016; 6: 35945.","DOI":"10.1038\/srep35945"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Beavers DL, Wang W, Ather S, <i>et al<\/i>. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. J Am Coll Cardiol 2013; 62: 2010-9.","DOI":"10.1016\/j.jacc.2013.06.052"},{"key":"22","unstructured":"22. Minamisawa S, Oshikawa J, Takeshima H, <i>et al<\/i>. Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. Biochem Biophys. Res Commun 2004; 325: 852-6."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wei S, Guo A, Chen B, <i>et al<\/i>. T-tubule remodeling during transition from hypertrophy to heart failure. Circ Res 2010; 107: 520-31.","DOI":"10.1161\/CIRCRESAHA.109.212324"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Landstrom AP, Kellen CA, Dixit SS, <i>et al<\/i>. Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling. Circ Heart Fail 2011; 4: 214-23.","DOI":"10.1161\/CIRCHEARTFAILURE.110.958694"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. van Oort RJ, Garbino A, Wang W, <i>et al<\/i>. Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice. Circulation 2011; 123: 979-88.","DOI":"10.1161\/CIRCULATIONAHA.110.006437"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Reynolds JO, Chiang DY, Wang W, <i>et al<\/i>. Junctophilin-2 is necessary for T-tubule maturation during mouse heart development. Cardiovasc Res 2013; 100: 44-53.","DOI":"10.1093\/cvr\/cvt133"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chen B, Guo A, Zhang C, <i>et al<\/i>. Critical roles of junctophilin-2 in T-tubule and excitation-contraction coupling maturation during postnatal development. Cardiovasc Res 2013; 100: 54-62.","DOI":"10.1093\/cvr\/cvt180"},{"key":"28","unstructured":"28. Lubrano R, Versacci P, Guido G, Bellelli E, Andreoli G, Elli M. Might there be an association between polycystic kidney disease and noncompaction of the ventricular myocardium? Nephrol Dial Transplant 2009; 24: 3884-6."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Oflaz H, Alisir S, Buyukaydin B, <i>et al<\/i>. Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease. Kidney Int 2005; 68: 2244-9.","DOI":"10.1111\/j.1523-1755.2005.00682.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pedrozo Z, Criollo A, Battiprolu PK, <i>et al<\/i>. Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability. Circulation 2015; 131: 2131-42.","DOI":"10.1161\/CIRCULATIONAHA.114.013537"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Boulter C, Mulroy S, Webb S, Fleming S, Brindle K, Sandford R. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci U S A 2001; 98: 12174-9.","DOI":"10.1073\/pnas.211191098"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Paavola J, Schliffke S, Rossetti S, <i>et al<\/i>. Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. J Mol Cell Cardiol 2013; 58: 199-208.","DOI":"10.1016\/j.yjmcc.2013.01.015"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-155\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:56:44Z","timestamp":1601697404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-155\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-155","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}